Patents by Inventor Tadao Aoki

Tadao Aoki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5491150
    Abstract: A supplementary therapeutic agent for the treatment of immunodeficiency syndrome with reduced NK (natural killer) activity and an immunopotentiator preparation containing it are provided.A supplementary therapeutic agent for immunopotentiation which comprises L-cysteine, L-cystine, or L-glutamine, or salts thereof and is used in combination with an immunopotentiator such as lentinan, OK-432, sizofiran or the like, and an immunopotentiator preparation containing the agent. This combination of agents is useful as a supplementary therapeutic agent for the treatment of an immunodeficiency, such as low NK activity syndrome, chronic fatigue syndrome, acquired immunodeficiency syndrome, or congenital immunodeficiency syndromes.
    Type: Grant
    Filed: January 27, 1994
    Date of Patent: February 13, 1996
    Assignee: Ajinomoto Co., Inc.
    Inventors: Tadao Aoki, Hideo Miyakoshi
  • Patent number: 4426454
    Abstract: A diagnostic method for immune disorders comprising determining the immunoglobulin production or the DNA (deoxyribonucleic acid) synthesis of peripheral blood lymphocytes by stimulation with a new mitogen derived from either disintegrated microorganisms or culture fluid of microorganisms belonging to Staphylococcus.
    Type: Grant
    Filed: March 23, 1981
    Date of Patent: January 17, 1984
    Assignee: Fujirebio Kabushiki Kaisha
    Inventors: Tadao Aoki, Hideo Miyakoshi, Mikio Mizukoshi
  • Patent number: 4391802
    Abstract: A method of leukemia or leukemoid disease treatment by administration of a vitamin D derivative with a hydroxyl group at 1.alpha.-position is disclosed. It is believed that the vitamin D derivative with a hydroxyl group at 1.alpha.-position is capable of treating cancer through redifferentiation of cancer cells and that this capability is inherent in vitamin D derivatives with a hydroxyl group at 1.alpha.-position.
    Type: Grant
    Filed: March 9, 1982
    Date of Patent: July 5, 1983
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Tatsuo Suda, Yoshihei Hirasawa, Sachio Takahashi, Etsuko Abe, Kunio Konno, Tadao Aoki
  • Patent number: 4340604
    Abstract: A method for inhibiting the lowering of immunological function of patients who are suffering from serious renal disorder such as chronic renal failure or uremia which comprises administering 1.alpha.-hydroxycholecalciferol to the patients is disclosed. An agent useful in the practice of the method is also disclosed.
    Type: Grant
    Filed: August 11, 1980
    Date of Patent: July 20, 1982
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Tadao Aoki, Hideo Miyakoshi, Yoshihei Hirasawa, Yasuo Nishii